Showing results (31-40 of 75) with videos related to
Sort By:
Pageof 8
Therapeutische Umschau. Revue Therapeutique|October 12, 1999
[Patient with recurrent gastrointestinal hemorrhage in acquired von Willebrand disease]G M Baerlocher, L Leoncini-Franscini, W A Wuillemin, et al.Schweizerische Medizinische Wochenschrift|October 30, 1999
[Activation of plasma cascade systems in sepsis: role of C1 inhibitors]S Zeerleder, C Caliezi, M Redondo, et al.British Journal of Haematology|February 1, 1996
Thrombin-mediated activation of endogenous factor XI in plasma in the presence of physiological glycosaminoglycans occurs only with high concentrations of thrombinW A Wuillemin, K Mertens, H ten Cate, et al.Hamostaseologie|August 19, 2003
Disseminated intravascular coagulation in meningococcal sepsis. Case 7S Zeerleder, R Zürcher Zenklusen, C E Hack, et al.Hamostaseologie|August 19, 2003
Severe nose bleeding after intake of acetylsalicylic acid: von Willebrand disease type 2A. Case 9N X von der Weid, B Mansouri Taleghani, W A WuilleminComplement and Inflammation|January 1, 1991
Clinical manifestations in humans of combined C7 and C4 deficiency associated with low levels of C2, C8, and C9W A Wuillemin, P J Späth, B Uring-Lambert, et al.Praxis|January 28, 1997
[The significance of APC resistance (activated protein C) for clinical practice]B Lämmle, F Demarmels Biasiutti, W A Wuillemin, et al.Annals of Hematology|December 24, 1997
Subcutaneous low-molecular-weight heparin for treatment of Trousseau's syndromeM Züger, F Demarmels Biasiutti, W A Wuillemin, et al.Journal of Thrombosis and Haemostasis : JTH|July 24, 2009
Study of bioaccumulation of dalteparin at a therapeutic dose in patients with renal insufficiencyP Schmid, D Brodmann, Y Odermatt, et al.Clinical and Experimental Immunology|February 15, 2017
Mutational spectrum of the SERPING1 gene in Swiss patients with hereditary angioedemaU C Steiner, M Keller, P Schmid, et al.Pageof 8